Download PDF
Thromb Haemost 1995; 73(02): 328-329
DOI: 10.1055/s-0038-1653776
Letter to the Editor
Schattauer GmbH Stuttgart

Loss of Heparin-Releasable Tissue Factor Pathway Inhibitor in Patients Undergoing PTCA

S Anderson
Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK
,
A T Cohen
Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK
,
E Melissari
Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK
,
M S Scully
Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK
,
V V Kakkar
Thrombosis Research Institute, Emmanuel Kaye Building, Chelsea, London, UK
› Author Affiliations
Further Information

Publication History

Received 13 September 1994

Accepted after revision 28 October 1994

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Rapaport S. The extrinsic pathway inhibitor: A regulator of tissue-factor dependent blood coagulation. Thromb Haemost 1991; 66: 6-15
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Broze Jr GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546
    CrossrefPubMedGoogle Scholar
  • 3 Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinoly 1992; 3: 439-449
    PubMedGoogle Scholar
  • 4 Ariens RA S, Faioni EM, Mannucci PM. Repeated release of the tissue factor pathway inhibitor. Thromb Haemost 1994; 72: 327-328
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1982; 47: 627-636
    PubMedGoogle Scholar
  • 6 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Selective expression of tissue factor in the normal vessel wall in the atherosclerotic plaque. Proc Natl AcadSci USA 1989; 86: 2829-2834
    CrossrefPubMedGoogle Scholar